secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bellerophon Therapeutics, Inc. (—)
CIK:        0001600132
Form:       8-K
Filed at:   2023-07-24T23:59:59+00:00
Accession:  0001104659-23-083433
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellerophon receives Nasdaq delisting notice over public shell status and bid price non-compliance
--------------------------------------------------------------------------------

- Nasdaq notified Bellerophon on July 19, 2023 of delisting effective July 28 unless hearing requested.
- Staff believes company is a 'public shell' and fails $1.00 bid price requirement (Rule 5550(a)(2)).
- Company plans to timely request a hearing; stock remains listed pending hearing outcome.
- Workforce reduction and exploration of strategic alternatives previously disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600132/000110465923083433/0001104659-23-083433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600132/000110465923083433/tm2321917d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-083433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer